{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:44:36Z","timestamp":1757706276156,"version":"3.40.5"},"reference-count":0,"publisher":"Elsevier BV","issue":"4","funder":[{"DOI":"10.13039\/501100003069","name":"Instituto Polit\u00e9cnico Nacional","doi-asserted-by":"publisher","award":["Proyectos Insignia IPN-2015","COFAA-SIP\/IPN"],"award-info":[{"award-number":["Proyectos Insignia IPN-2015","COFAA-SIP\/IPN"]}],"id":[{"id":"10.13039\/501100003069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"CONACYT","doi-asserted-by":"publisher","award":["CB-254600","APN-782"],"award-info":[{"award-number":["CB-254600","APN-782"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMP"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Valproic acid (VPA) is an HDAC inhibitor (HDACI) with an anticancer\nactivity, but is hepatotoxic. N-(2-hydroxyphenyl)-2-propylpentanamide (o-OH-VPA) is a VPA aryl\nderivative designed in silico as a selective inhibitor of HDAC8 with biological properties against\nHeLa, rhabdomyosarcoma and breast cancer cell cultures.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> We studied the epigenetic mechanism of o-OH-VPA as an HDACI and evaluated\nwhether it was toxic to normal cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>HeLa cells and primary human fibroblasts were used for this study as carcinogenic and\nnormal cells, respectively. Cell survival was evaluated by MTT assay, whereas viability and doubling\ntime were determined by the Trypan-blue method. HDAC activity was tested using the colorimetric\nHDAC activity assay. The expression of p21 was analyzed by PCR and HDAC8 expression\nwas also evaluated by real-time PCR. Cell cycle and caspase-3 activity were analyzed by flow cytometry\nand caspase-3 colorimetric assay, respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>o-OH-VPA (IC<jats:sub>50<\/jats:sub> = 0.1 mM) was fifty-eight times more effective than VPA (IC<jats:sub>50<\/jats:sub> = 5.8\nmM) to reduce HeLa cell survival. Furthermore, o-OH-VPA increased the doubling time of HeLa\ncells by 33% with respect to the control. o-OH-VPA acted as HDACI in HeLa cells without affecting\nthe HDAC8 expression, arresting the cell cycle of HeLa cells in the G0\/G1 phase due to the increase\nin p21 expression with the inhibition of caspase-3 activity without exhibiting toxicity toward\nnormal cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our results revealed that o-OH-VPA is an HDACI with a selective effect against\nHeLa cells but without the known toxicity exerted by most pan-HDACIs on normal cells.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1874467213666200730113828","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T17:31:53Z","timestamp":1596475913000},"page":"570-578","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Epigenetic Evaluation of N-(2-hydroxyphenyl)-2-Propylpentanamide, a Valproic Acid Aryl Derivative with Activity Against HeLa Cells"],"prefix":"10.1016","volume":"14","author":[{"given":"G.R.","family":"Luna-Palencia","sequence":"first","affiliation":[{"name":"Departamento de Biotecnologia y Bioingenieria, Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Av. IPN 2508, San Pedro Zacatenco, CDMX, 07360,Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Correa-Basurto","sequence":"additional","affiliation":[{"name":"Laboratorio de Diseno y Desarrollo de Nuevos Farmacos e Innovacion Biotecnologica (Laboratory for the Design and Development of New Drugs and Biotechnological Innovation), Escuela Superior de Medicina, Instituto Politecnico Nacional, Plan de San Luis y Diaz Miron s\/n, Casco de Santo Tomas, CDMX, 11340,Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Trujillo-Ferrara","sequence":"additional","affiliation":[{"name":"Laboratorio de Bioquimica, Laboratorio de Modelado Molecular, Bioinformatica y Diseno de Farmacos de la Escuela Superior de Medicina, Instituto Politecnico Nacional, Plan de San Luis y Diaz Miron s\/n, Casco de Santo Tomas, CDMX, 11340,Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Meraz-R\u00edos","sequence":"additional","affiliation":[{"name":"Departamento de Biomedicina Molecular, Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional,Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8792-7858","authenticated-orcid":true,"given":"I.","family":"V\u00e1squez-Moctezuma","sequence":"additional","affiliation":[{"name":"Laboratorio de Morfologia de la Maestria en Ciencias de la Salud, Escuela Superior de Medicina, Instituto Politecnico Nacional, Plan de San Luis y Diaz Miron s\/n, Casco de Santo Tomas, CDMX, 11340,Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/184355","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184355\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/184355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:57:03Z","timestamp":1746572223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184355\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874467213666200730113828","relation":{},"ISSN":["1874-4672"],"issn-type":[{"type":"print","value":"1874-4672"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}